| NCT05188729 | Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma | COMPLETED | PHASE2 | 2022-02-01 | 2024-04-15 | 2024-04-15 |
| NCT03981822 | A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts | COMPLETED | PHASE2 | 2019-06-25 | 2020-07-08 | 2020-05-21 |
| NCT03487549 | Cantharidin and Occlusion in Verruca Epithelium | COMPLETED | PHASE2 | 2018-03-27 | 2019-07-15 | 2019-05-16 |
| NCT03377790 | Cantharidin Application in Molluscum Patients-1 | COMPLETED | PHASE3 | 2018-03-21 | 2018-11-26 | 2018-11-26 |
| NCT03377803 | Cantharidin Application in Molluscum Patients | COMPLETED | PHASE3 | 2018-02-14 | 2018-09-26 | 2018-09-26 |
| NCT03186378 | Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum. | COMPLETED | PHASE2 | 2017-06-08 | 2018-06-25 | 2018-06-25 |